Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) (“GENIX” or the “Company”) announces that the Company has made an application to the TSX Venture Exchange (the “Exchange”) to amend the exercise price, the warrant accelerator terms and extend the expiry date of 3,354,945 previously issued and outstanding warrants (the “Warrants”).
January 19, 2024
· 3 min read